[15]郑建珅,闫会丽.注射用牛肺表面活性剂联合布地奈德防治新生儿支气管肺发育不良的效果[J].中国实用医刊,2021,48(16):102-106.[16]饶军,程贤高,李晓春,等.布地奈德联合肺表面活性物质气管内注入防治早产儿支气管肺发育不良的效果[J].医学信息,2020,33(23):147-149.[17]GalambosC,Sims-LucasS,AliN,etal.Intrapulmonaryvascularshuntpathwaysinalveolarcapillarydysplasiawithmisalignmentofpulmonaryveins[J].Thorax,2015,70(1):84-85.[18]PolinRA,CarloWA,CommitteeonFetusandNewborn,etal.Surfactantreplacementtherapyforpretermandtermneonateswithrespiratorydistress[J].Pediatrics,2014,133(1):156-163.[19]杜凤玲,董文斌,赵帅,等.布地奈德联合猪肺磷脂注射液预防早产儿支气管肺发育不良[J].中华实用儿科临床杂志,2016,31(11):846-850.[20]柯胜忠,张多.支气管肺发育不良患儿发生急性病毒性下呼吸道感染的预测因素分析[J].中国免疫学杂志,2018,34(6):911-914.[21]黄智峰,李欢,黄鹏,等.早期雾化吸入布地奈德预防极低出生体质量儿支气管肺发育不良[J].中华实用儿科临床杂志,2018,33(2):117-119.[22]谢健兴,谭绍葵,韦显威,等.布地奈德雾化吸入联合维生素A口服防治早产儿支气管肺发育不良临床分析[J].广西医科大学学报,2018,35(7):1005-1007.[23]DodsworthC,BurtonBK.IncreasedincidenceofneonatalrespiratorydistressininfantswithmucopolysaccharidosistypeII(MPSII,Huntersyndrome)[J].MolGenetMetab,2014,111(2):203-204.[24]WambachJA,WegnerDJ,HeinsHB,etal.SynonymousABCA3variantsdonotincreaseriskforneonatalrespiratorydistresssyndrome[J].JPediatr,2014,164(6):1316-1321.[25]CuevasGuamanM,SbranaE,ShopeC,etal.Administrationofan-tenatalglucocorticoidsandpostnatalsurfactantamelioratesrespiratorydistresssyndromeassociatedneonatallethalityinErk3mousepups[J].PediatrRes,2014,76(1):24-32.修回日期:2022-09-20本文编辑:刘亚男·儿童保健/论著·122例胎龄<32周早产儿输注红细胞相关因素分析李玉蕊,张雪峰解放军总医院第五医学中心新生儿科,北京100071通信作者:张雪峰,E-mail:doctor1966@sina.com摘要:目的了解早产儿贫血(<32周)输血现状,探讨早产儿输血治疗的指征和影响因素,为新生...